News Highlights
Thought Leadership
-
-
November 28 2022Adjustment of Covariates in Randomized Trials
-
-
September 16 2022Risk-based Monitoring and the Monitor's Roles - Part 2
-
August 31 2022Risk-based Monitoring and the Monitor's Roles - Part 1
-
Chelsey Ryan, PMP
PROMETRIKA’s agility and technical innovation make our team a collaborative extension of our Sponsor partners. Our highest priority is to develop fit-for-purpose, project-specific clinical trial solutions that deliver high quality results and adhere to regulatory requirements.
Chelsey Ryan, PMP
SPECIALIZED SERVICES
-
STRATEGIC CONSULTING
-
NDA & MAA SUBMISSIONS
-
ADAPTIVE DESIGN
-
DECENTRALIZED CLINICAL TRIALS
-
IDMC SERVICES
-
CDISC
SDTM & ADaM -
PROTOCOL DEVELOPMENT
-
POST MARKETING
FOCUS ON RARE DISEASES
We have experience in rare disease clinical trials that includes more than 85 studies in a broad range of indications.
FOCUS ON ONCOLOGY
Oncology represents one of PROMETRIKA’s top three therapeutic areas of experience.
OUR STORY
PROMETRIKA was founded in 2003 and started operations as a data management, biostatistics, and medical writing functional service provider. In 2007, we added clinical operations and pharmacovigilance and became a full-service Clinical Research Organization. Since then, PROMETRIKA has provided two decades of experienced, professional support to local, national, and international clients and has gained a reputation for quality and excellence. Let us tell you about our journey!